Corvia Medical said it launched a heart failure device trial that will include the collection and analysis of data with PhysIQ’s continuous remote monitoring platform. The Phase III trial is designed to evaluate the efficacy of Tewksbury, Mass.-based Corvia’s interatrial shunt in patients with heart failure. The randomized, controlled, double-blinded study includes plans to provide […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Man charged in death of Medtronic research scientist
This article has been updated with charging information from the Hennepin County (Minn.) Attorney’s Office. Officials in Minneapolis have charged a man with manslaughter in the August 23, 2019, death of a Medtronic research scientist. Hennepin County officials said they have charged Erik Kravchuk, 28, of Golden Valley, Minn. with first-degree manslaughter in the death […]
BioSig inks deal with Mayo Clinic
BioSig Technologies (NSDQ:BSGM) said yesterday that it signed a new licensing agreement with Mayo Clinic to further its Pure EP system, less than two months after the Mayo Clinic invested $1 million in BioSig’s first product. Westport, Conn.-based BioSig and the Rochester, Minn.-based clinic inked a 10-year strategic partnership agreement for the Pure EP system’s […]
V-Wave’s interatrial shunt lands another breakthrough nod from FDA
V-Wave said yesterday that it won FDA breakthrough device designation for its interatrial shunt for pulmonary arterial hypertension, marking the second time in less than a month that the company has earned a breakthrough nod. The PAH shunt is designed to be placed in the heart through a catheter inserted via a vein in the […]
FDA clears HeartFlow Planner
HeartFlow said yesterday that it won FDA clearance for its Planner tool for coronary artery disease intervention. The Redwood City, Calif.-based company developed FFRct, which works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing changes in flow across coronary lesions. The Planner virtual […]
CroíValve adds $4.4m to initiate clinical trials
CroíValve said today that it secured more than $4 million in additional financing as it develops a treatment for tricuspid regurgitation. The funding, which amounts to more than $4.4 million (€4 million) includes more than $2.7 million (€2.5 million) from the European Union under its Horizon 2020 SME Instrument grant. The remaining $1.7 million (€1.5 […]
Cardiac Dimensions touts Carillon TMVR study
Cardiac Dimensions today touted a clinical study of its Carillon mitral contour system in treating the primary cause of functional mitral regurgitation (FRM) in patients with heart failure. Carillon is a right heart transcatheter mitral valve repair (TMVR) device designed to treat FRM in patients with mitral regurgitation grades of 2+, 3+ and 4+ in […]
Apple announces medical studies using new Research app
Apple (NSDQ:AAPL) said yesterday that it is launching medical studies into women’s health, hearing, and heart function and movement with its new Research app. The Cupertino, Calif.-based company said the app will show how medical research is conducted and allow participants to contribute to potential medical discoveries. The Research app will be available as a free […]
CryoLife, EndoSpan ink distribution deal
CryoLife Inc. (NYSE:CRY) today announced that it has signed a strategic distribution and credit facility agreement with Endospan with an option to purchase the company. Kennesaw, Georgia-based CryoLife will have exclusive distribution rights to Endospan’s Nexus stent graft system in Europe. CryoLife will pay $10 million upfront and provide up to $15 million in debt financing […]
Ventrix touts first-in-human study of hydrogel to repair heart muscle
Bio-scaffold startup Ventrix said today it has safely conducted a first-in-human trial of an injectable hydrogel to repair cardiac tissue in patients who have suffered a heart attack. The FDA-approved, Phase 1 trial is the first to test a hydrogel made from the natural scaffolding of cardiac muscle tissue, also known as extracellular matrix, or […]
CorWave touts LVAD study results
CorWave today touted 60-day study results from its preclinical study to evaluate its left ventricular assist device. The study concluded that the company’s LVAD has the ability to provide chronic circulatory support with outstanding hemocompatibility. “We were thrilled by the performance of the pump. This study bolsters the excellent hemocompatibility data from our previous trials, […]